Research for application to anesthesia of gabapentine that is a chemical delivative of GABA with central nervous system depressant property.

Research for application to anesthesia of gabapentine that is a chemical delivative of GABA with central nervous system depressant property. - Research for application to anesthesia of gabapentine that is a chemical delivative of GABA with central nervous system

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000015604

Enrollment

Registered

2014-11-06

Start date

2014-11-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy people

Interventions

placebo group of gabapenntine 200mg group of gabapenntine 400mg

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: based on protocol

Exclusion criteria

Exclusion criteria: based on protocol

Design outcomes

Primary

Measure	Time frame
blood concentration of propofol for getting around to of same depth of anesthesia	—

Secondary

Measure	Time frame
angialgia of propofol	—

Countries

Japan

Contacts

Public ContactJun Hirokawa

kyushu university dental anesthesiology

hj8823@dent.kyushu-u.ac.jp092-642-6480

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026